T he use of dopamine or norepinephrine as first-line agents in septic shock treatment has recently been recommended by the Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (1) . Dopamine increases mean arterial pressure primarily by increasing cardiac index with minimal effects on systemic vascular resistance (2) . Thus, dopamine fails to increase mean arterial pressure when systemic vascular resistance is too low. "Dopamine-resistant septic shock" was previously defined by the persistence of low arterial pressure despite the use of 20 g/kg/min dopamine (3) . Currently, it is unknown whether the use of a particular catecholamine regimen is able to influence patient outcome (4, 5) .
Clinical criteria generally used to definite septic shock do not allow for early identification of patients with good or bad prognosis. Mortality in septic shock is usually reported in heterogeneous populations (6) . Our hypothesis is that "dopamine-sensitive" patients have a better prognosis than those with a "dopamine-resistant" profile. This is important since the ability to prospectively identify patients with poor outcome is particularly helpful in properly designing clinical trials, in guiding therapy, and notably in implementing new therapeutic strategies (7) .
Hence, the present report is a prospective, multiple-center study that evaluates the predictive value of dopamine resistance on mortality rate and characterizes septic shock patients according to their dopamine responsiveness.
MATERIALS AND METHODS

Experimental Design and Study Organization
Ten medical or medical-surgical adult intensive care units (ICUs) from ten hospitals (four university hospitals, one regional hospital, and five general hospitals) participated in the study. This study was approved by our institutional review board. The study was initiated in July 2001 and ended in April 2002. At the end of the study, an independent diagnosis validation committee blindly classified each patient as either unquestionably having had septic shock, probably having had septic shock, or unlikely to have had septic shock. All patients Ն18 yrs hospitalized in participating ICUs were prospectively enrolled in the study if they met all the following criteria: a) a documented site (or at least strong suspicion) of infection, as evidenced by one or more of the following: presence of polymorphs in a normally sterile body fluid (except blood), positive culture or Gram-negative stain of a normally sterile body fluid, clinical focus on infection (e.g., fecal peritonitis), wound with purulent discharge, pneumonia or other clinical evidence of systemic infection (e.g., purpura fulminans); b) temperature Ͼ38.3°C or Ͻ35.6°C; c) heart rate Ͼ90 beats/min; e) urinary output Ͻ0.5 mL/kg of body weight for Ն1 hr or PaO 2 /FIO 2 ratio of Ͻ280 mm Hg; e) arterial lactate levels Ͼ2 mmol/L; f) need for mechanical ventilation; and g) systolic blood pressure Ͻ90 mm Hg or a 40 mm Hg decrease below baseline or mean arterial pressure Ͻ70 mm Hg and nonresponsiveness to fluid therapy (8) .
Therapeutic Protocol
To prevent discrepancy among patients in terms of catecholamine support, guidelines established by the French Society of Intensive Care Medicine were used (9) . Phase 1. After failure of vascular loading, incremental infusion of dopamine, from 10 to 20 g/kg/min, was used. Infusion rate was increased by 5 g/kg/min every 10 mins up to a maximum dose of 20 g/kg/min and adjusted to maintain a mean arterial pressure Ն 70 mm Hg (10) . Hence, the time needed to reach the highest dose of 20 g/kg/min was 30 mins.
Phase 2. Dopamine resistance was defined by a mean arterial pressure Ͻ70 mm Hg despite a 20-g/kg/min infusion of dopamine. Moreover, dopamine was stopped when it induced rhythm disturbances. In the case of dopamine-resistant septic shock, hemodynamic evaluation was assessed by pulmonary artery catheter, esophageal Doppler, or echocardiography. The recommendations were to assess the adequacy of vascular loading using cardiac output variation after volume loading.
Patients were considered as responders when the increase was Ͼ15%. Volume resuscitation was considered optimal when, at a given level, additional fluid infusion was no longer accompanied by an increase in cardiac index.
Norepinephrine or epinephrine (0.5-5 g/ kg/min) with/without dobutamine (5-15 g/ kg/min) was administered. If shock remained refractory, no further recommendations were elicited.
Weaning of drugs was performed after a 12-to 24-hr period of hemodynamic stability, using decreasing doses of catecholamine every 30 mins. There was no specific recommendation for the use of low-dose hydrocortisone (200 -300 mg/day).
Data Collection at Inclusion
Clinical Evaluation. On admission, the following variables were recorded: a) general characteristics including age and gender, date of ICU admission, and category of admission; b) severity of illness as by Simplified Acute Physiology Score II and Sepsis-related Organ Failure Assessment (SOFA) score; c) vital signs including body temperature, mean arterial pressure, heart rate, and urinary output; and c) interventions including volume of fluid infusion per 24 hrs, type and titration of catecholamines, and need for sedation or renal therapy.
Laboratory Analyses. Hematologic and biochemical data, arterial lactate and blood gas determinations, and blood cultures and specimen cultures drawn from the site of infection were systematically performed.
Follow-Up. The following data were recorded daily during the 28-day study period following enrollment in the study: vital signs, SOFA score, results from standard laboratory tests and specimen cultures drawn from any new site of infection, and all interventions. In addition, the patient's status at discharge from ICU and hospital and 1 yr after was recorded. Reversal of shock was defined by a stable mean arterial pressure (Ͼ70 mm Hg) for Ͼ24 hrs without catecholamine or additional volume loading (11) .
Statistical Analysis
The prognostic value for the probability of dying was investigated based on patient characteristics collected during the first 24 hrs of septic shock. Statistical analyses were conducted using the SAS software package (version 6.12, SAS Institute, Cary, NC). Univariate analyses between survivors and nonsurvivors were conducted using the Student's t-test for continuous variables and Pearson's chi-square test for categorical variables (or the Fisher's exact test when appropriate). Survival was estimated by the Kaplan-Meier method, and intergroup comparisons were performed using the log-rank test for all variables. All variables found to be significantly different between Data are presented as mean Ϯ SD or as number (%). Data are presented as mean Ϯ SD or as number (%).
survivor and nonsurvivor groups, according to the univariate analysis, were entered into the logistic regression model. Multivariate analyses were performed using a logistic regression model to estimate the odds ratio of dying (along with the 95% confidence interval [CI] ). Calibration of the logistic model was assessed using the Hosmer-Lemeshow goodness-of-fit test to evaluate the importance of the discrepancy between observed and expected mortality rates. A Cox proportional hazards regression model was used to assess variables related to death (12) . This model assumes that the effect of a variable on the instantaneous death rate is constant over time. This assumption was checked for all predictor variables entered in the model. Stepwise and backward selection procedures were used for both regression models (logistic and Cox) to iteratively select the variables that were significantly related to death, as assessed by the likelihood ratio test. Effectiveness in predicting outcome was compared by calculating the sensitivity and specificity for each variable and the combination of both. For lactate level, we used receiver operating characteristic curve to determine the best cutoff. For all tests, p Ͻ .05 was considered statistically significant.
RESULTS
Overall mortality rate was 59 of 110 (53.6%). At baseline, both survivor and nonsurvivor groups were balanced with respect to general characteristics ( Table  1 ) and severity of illness (Table 2 ) except for the occurrence of liver disease. The type and site of infection as well as type of organism involved were also similar in both groups (Table 3) . Finally, a blinded evaluation determined that appropriate antibiotic therapy, based on the site of infection and/or available cultures, was promptly started (Ͻ4 hrs from diagnosis of septic shock) and continued for Ն7 days in 96% and 93% of surviving and nonsurviving patients, respectively.
Univariate analysis was performed to compare survival time distributions of all variables collected during the first 24 hrs of septic shock using the log-rank test. Variables associated with death were McCabe score of Ͼ1 (p ϭ .005), Simplified Acute Physiology Score II Ͼ50 (p Ͻ .001), SOFA score Ͼ10 (p Ͻ .001), hydrocortisone use (p ϭ .05), mean arterial pressure Յ60 mm Hg (p Ͻ .001), arterial lactate level Ͼ3.5 mmol/L (p Ͻ .001), platelet count Ͻ100 ϫ 10 3 L (p Ͻ .05), and dopamine resistance (p Ͻ .001). Variables identified by the univariate analysis with the log-rank test (aside from physician interventions) were entered in the Cox proportional hazards regression model to identify variables that had an important impact on mortality rate. Of those variables, three remained independently associated with mortality rate as shown in Table 4 : dopamine resistance, arterial lactate level Ͼ3.5 mmol/L, and SOFA score Ͼ10. Dopamine resistance Figure 1 . Timing of dopamine resistance. Of the 110 patients, 66 were observed to be resistant to dopamine (60%). All dopamine-resistant patients except for three became resistant to dopamine before 24 hrs. Data are presented as number (%). was associated with the highest odds of dying at 9.50 (CI, . Lactate level Ͼ 3.5 mmol/L was associated with a 1.75 odds of dying (CI, 1.06 -2.55) whereas a SOFA score Ͼ 10 was associated with a 1.4 odds of dying (CI, 1.07-2.12). The Hosmer-Lemeshow goodness-of-fit test showed that the model was well calibrated with p ϭ .493 (a large p value indicating that there is not a large discrepancy between observed and expected mortality rates). The capacity of dopamine resistance to predict death was associated with a sensitivity of 84% (95% CI, 78 -90) and a specificity of 74% (95% CI, 68 -80). We found a threshold value of 2.7 mmol/L for lactate at 24 hrs. Table 5 depicts the prognostic value of dopamine resistance, blood lactate concentration, and dopamine resistance plus elevated lactate at 24 hrs. The addition of blood lactate concentration improves the sensitivity and the specificity.
Comparison Between Dopamine-Sensitive (Dopa-S) and Dopamine-Resistant (Dopa-R) Patients
Of the 110 patients, 66 were observed to be resistant to dopamine (60%). All Dopa-R patients except for three became resistant to dopamine before 24 hrs. Treatment was switched to other catecholamines when dopamine dosage reached 18.6 Ϯ 3 g/kg/min (Tables 6  and 7) . None of the patients was scored as Dopa-R due to rhythm disturbances. The mean observed delay for concluding a failure of dopamine treatment was 16 Ϯ 10 hrs (Table 7 and Fig. 1 ). Ten of 66 Dopa-R patients remained resistant to vasopressor therapy.
Mortality rate was 16% (seven of 44 patients) for the Dopa-S group compared with 79% (52 of 66 patients) for the Dopa-R group (p ϭ .0006, Table 7) There was no difference in terms of medical history between Dopa-S and Dopa-R groups. Severity of illness and number of organ failures as assessed by Simplified Acute Physiology Score II and SOFA scores as well as lactate levels were higher both on admission and at enrollment in the Dopa-R group (Table 7) . Shock reversal was observed in 91% (40 of 44) and 24% (16 of 66) of patients in the Dopa-S and Dopa-R groups, respectively (p ϭ .01). The delay for shock reversion was shorter in the Dopa-S group than in the Dopa-R group (85 Ϯ 44 vs. 151 Ϯ 120 hrs, p ϭ .001, Table 7) . Figure 2 shows the Kaplan-Meier survival curves for Dopa-S and Dopa-R patients. Dopamine resistance was associated with a significantly higher rate of mortality (p ϭ .006) (4) Dopa-S, dopamine-sensitive; Dopa-R, dopamine-resistant. The numbers in parentheses are the numbers of patients treated with the specific vasoactive agent. 
Survival Analysis
Hour 6 n ϭ 44 n ϭ 65 Dopamine 9 Ϯ 7 (44) 12 Ϯ 5 (48) Epinephrine 1.3 Ϯ 1.2 (16) Norepinephrine 1.3 Ϯ 0.9 (9) Dobutamine 6 Ϯ 2 (18) Hour 24 n ϭ 43 n ϭ 53 Dopamine 9 Ϯ 4 (43) 13 Ϯ 5 (3) Epinephrine 2.3 Ϯ 1.6 (18) Norepinephrine 2.0 Ϯ 2.4 (35) Dobutamine 8 Ϯ 4 (29) Day 3 n ϭ 29 n ϭ 38 Dopamine 9 Ϯ 5 (29) 7.6 Ϯ 4 (3) Epinephrine 7.3 Ϯ 6.1 (13) Norepinephrine 1.6 Ϯ 4.0 (25) Dobutamine 2 Ϯ 2 (22) Day 10 n ϭ 0 n ϭ 7 Dopamine 4.9 Ϯ 6.2 (6) Epinephrine 0.3 Ϯ 0.2 (1) Norepinephrine Dobutamine 6 Ϯ 3
DISCUSSION
The key demonstration of the present study is that an early response to dopamine is an accurate and early predictor of outcome in catecholamine-treated septic shock patients.
Hemodynamic severity of septic shock is linked to acuteness of vasoplegia (13) . In this setting, dopamine, via its primary ␤1 stimulating action, is essentially an inotropic agent with little effect on vascular resistance. Nevertheless, in a random population of septic shock, 40% of patients exhibit an increase in arterial pressure with dopamine alone and ultimately do not require other vasoconstrictors.
Many previous studies demonstrated the relationship between catecholamine requirement and mortality rate. Nevertheless, this study demonstrates for the first time the temporal relationship between patient prognosis and catecholamine dosages, together with a precise protocol for administering catecholamines, thus enabling implementation of a therapeutic test that is nonstatic but rather progressive over time. This test will enable clinicians to evaluate patient prognosis at every moment of evolution and hence eventually trigger additional treatments such as activated protein C (14) . Moreover, the use of dopamine allows discrimination between two very differing groups with regard to mortality outcomes, thereby enabling the inclusion of homogeneous groups, in terms of severity, into multiple-center studies. Moreover, the association of dopamine resistance to a persistent elevated lactate markedly improved the prognostic value. The fact that lactate improved the prognostic value of dopamine resistance suggests that others factors than vascular failure account for patient prognostic.
Despite current guidelines, the use of dopamine is controversial since it could delay the use of norepinephrine, hence leading to persistent circulatory failure (15) . The present results clearly demonstrate that the rapid administration of incremental doses of dopamine followed by a switch to epinephrine or norepinephrine does not increase mortality rate when compared with other septic shock studies (4).
Limitations of the Study
At the time of the study period, there were no recommendations concerning the use of low-dose corticosteroids in septic shock (11, 16) . In the present study, a higher number of dopamine-resistant patients were treated with hydrocortisone compared with the dopamine-sensitive group. In the majority of cases, hydrocortisone was introduced after 5 days of catecholamine therapy. The use of hydrocortisone (30% of the study group) was not associated, however, with a different prognosis in univariate analysis.
This study was conducted before the Rivers et al. (17) study; thus, SCVO 2 monitoring was not used to guide fluid therapy. Despite a large amount of fluid received by our patients, we cannot definitively rule out the possibility that some patients were underresuscitated.
Moreover, considering the many largely differing approaches used by physicians in hemodynamic management of septic shock, we chose not to impose rightheart catheterization. Nevertheless, all dopamine-resistant patients had at least one hemodynamic investigation, and the amount of fluid received during the first 24 hrs was equal to that documented in the Rivers et al. study.
Conclusion
In septic shock, the use of initial predictive factors for identifying patient profile and prognosis is fundamental. We have demonstrated that the use of dopamine responsiveness is a reliable and independent predictive factor for mortality. The use of dopamine allows discrimination between two very differing groups with regard to mortality outcomes, thereby enabling the inclusion of homogeneous groups, in terms of severity, in multiple-center studies (18) . 
